Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical trial designs based on sequential conditional probability ratio tests and reverse stochastic curtailing

M Tan1, X Xiong, M H Kutner

  • 1Department of Biostatistics and Epidemiology, Cleveland Clinic Foundation, Ohio 44195-5196, USA. mtan@bio.ri.ccf.org

Biometrics
|June 18, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Global prevalence of FGFR2b protein overexpression in advanced gastric cancer and gastroesophageal junction cancers: pooled analysis of two bemarituzumab phase III studies.

ESMO open·2026
Same author

A phase 2 multicenter, prospective, randomized, double-blind study to assess the clinical and antiviral efficacy and safety of nitazoxanide for the treatment of norovirus in hematopoietic stem cell and solid organ transplant recipients.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026
Same author

Molecular and physiological acclimation to low light and iron scarcity in a globally abundant oceanic pelagophyte.

Nature communications·2026
Same author

The ASSIST CLAD study: A phase 2 randomized controlled trial of mesenchymal stromal cells for new-onset chronic lung allograft dysfunction.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026
Same author

Effect of Orem-based Nursing Intervention with Mobile Application on the Symptoms, Quality of Life, and Self-Care Abilities of Gastrointestinal Cancer Patients; A Quasi-Experimental Study.

Nigerian journal of clinical practice·2026
Same author

Beyond the surface: a case report of penile tuberculosis as the first sign of miliary disease in a solid organ transplant recipient.

ASM case reports·2026

This study introduces a group sequential method using the sequential conditional probability ratio test for clinical trials. It offers conservatism and accounts for potential discrepancies with fixed-sample tests, enabling flexible interim analyses without inflating type I error.

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Statistical Inference

Background:

  • Traditional fixed-sample trial designs lack flexibility for interim analyses.
  • Sequential methods are crucial for adaptive clinical trial designs.
  • Existing sequential methods may lack desired conservatism or introduce complexity.

Purpose of the Study:

  • To propose a novel group sequential method based on the sequential conditional probability ratio test.
  • To evaluate the conservatism and discordant probability of the proposed method.
  • To demonstrate its utility as a stochastic curtailing tool for adaptive trial management.

Main Methods:

  • Development of a group sequential method utilizing the sequential conditional probability ratio test.
  • Calculation of discordant probability to assess differences from fixed-sample tests.

Related Experiment Videos

  • Implementation via an interactive computer program for practical application.

    • Main Results:

    • The proposed method demonstrates desirable conservatism in practice.
    • Substantial discordant probabilities can occur even with equivalent size and power to fixed-sample tests.
    • The method effectively accommodates unplanned and planned interim analyses with minimal type I error inflation.

    Conclusions:

    • The new group sequential method provides a flexible and conservative approach to clinical trial design.
    • It allows for interim analyses while controlling statistical error rates.
    • The tool facilitates adaptive trial conduct, balancing efficiency and statistical rigor.